What's New

Antiretroviral treatment (ART) optimization is a key pillar in the AIDS Free agenda to reach the goal of ensuring 95% of all infants and children have access to lifesaving treatment. This policy brief outlines key considerations to facilitate effective transition to more clinically appropriate regimens as optimal ARV medicines and dosage forms become available.

The toolkit was developed under the umbrella of the Global Accelerator for Paediatric Formulations initiative to address some of the remaining challenges in developing HIV drugs for children and to serve as a global standard for accelerating high-quality research and development in this field. It provides an opportunity to capitalize on best practices and to set standards that enable drugs and formulations to be developed and introduced more rapidly. The aim of this toolkit is to facilitate faster, more efficient and focused development of new formulations for the effective treatment of infants, children and adolescents living with HIV by synthesizing key considerations for different stages of the drug development process.

Although access to effective HIV antiretroviral treatments has improved significantly – enabling people living with HIV to live long and productive lives including working and contributing to society in many different ways – people living with HIV continue to face discrimination in relation to work in terms of finding employment, keeping jobs and furthering career progression.

In 2016, Youth LEAD’s Strategic Plan for 2016-2018 commenced. 2017 was a year filled with achievements that aimed to target the five strategic priorities for Youth LEAD. Each of these priorities focuses on the needs of adolescent key populations (AKPs) and YKPs in the Asia-Pacific Region.

This provides an interactive report with colourful infographics and bite-size information on the HIV epidemic and response on key populations at higher risk of HIV in Myanmar.

The objectives are to determine national prevalence estimates and related risk behaviors for HIV and syphilis among entertainment workers (EW), to provide data for program planning and management of STI and HIV prevention programs for EW and their clients and to evaluate HIV/syphilis prevalence and behaviors among EW.

This handbook aims to facilitate the active involvement of People Living with HIV (PLHIV) in the Global Fund/Global Fund to Fight AIDS, Tuberculosis and Malaria Country Coordination Mechanism (GFATM CCM). It outlines basic values and principles, providing practical information and tools which can be adapted to national contexts. It stresses the ongoing importance of PLHIV led communication, coordination and consultation, so that people most affected by the three diseases can continually make their voices heard and weigh in on important issues. The ultimate goal of PLHIV representation on CCMs is to ensure that GFATM financed programs are efficient, impactful and sustainable.

The SDG Report presents an overview of progress toward achieving the Goals, which were unanimously adopted by countries in 2015. UN Under-Secretary-General for Economic and Social Affairs Liu Zhenmin said "Transitioning towards more sustainable and resilient societies also requires an integrated approach that recognizes that these challenges—and their solutions—are interrelated." As the global community moves forward to achieve the SDGs and address existing challenges, reliable, timely, accessible and disaggregated data is critically needed. This requires technology and innovation, increased resources and political commitment to build strong data and statistical systems in all countries.

Twenty years of evidence demonstrates that HIV treatment is highly effective in reducing the transmission of HIV. People living with HIV on antiretroviral therapy who have an undetectable level of HIV in their blood have a negligible risk of transmitting HIV sexually.

This report summarizes the progress in implementing the Global Action Plan achieved during the first year (2017 to 2018) and the remaining challenges, with specific focus on 45 countries accounting for more than 85% of the total burden of HIV infection.